Jeff Bezos’s net worth in 2025 is $242 billion. Bezos is a philanthropist and businessman. He is also considered to be the ...

Barbara J. Scott, 89, of Batavia passed away on Tuesday Jan. 28, 2025 at the United Memorial Medical Center. She was born on May 14, 1935 in Batavia to the late Floyd and Florence (Eichenberger ...

Once your Kindle has rebooted, open KUAL and choose "Remove from Crontab" from the Weather menu. This will prevent your Kindle from interrupting you every hour trying to display the weather. After ...

A day after the Dodgers welcomed Japanese sensation Roki Sasaki, they introduced lefty relief ace Tanner Scott to Los Angeles on Thursday afternoon. Scott’s four-year, $72 million contract became ...

AP Dhillon brings his A-game to Louis Vuitton’s Men's Paris Fashion Week 2025 show, joining BTS’ J-Hope, Travis Scott, and more stars in stylish extravaganza. Celebrities gather at Paris Men's ...

While the company's earnings beat was driven by its Innovative Medicines unit, mainly due to its multiple myeloma therapy, Darzalex, according to Bloomberg data on sales consensus, JNJ's MedTech ...

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

About 21 million U.S. adults in 2021 experienced at least one depressive episodes, latest government data shows. J&J said that about a third of adults will not respond to oral antidepressants alone.

Major depressive disorder (MDD) is characterised by characterised by depression and inability to feel pleasure. Credit: Justin Paget via Getty Images. Johnson & Johnson’s (J&J) nasal spray Spravato ...

With an FDA nod on Tuesday, Johnson & Johnson’s esketamine nasal spray Spravato became the industry’s first monotherapy approved for use in adults with treatment-resistant depression. The approval ...